Publicaciones en colaboración con investigadores/as de Hospital General Universitario Reina Sofía (26)

2021

  1. Exhaled volatilome analysis as a useful tool to discriminate asthma with other coexisting atopic diseases in women of childbearing age

    Scientific Reports, Vol. 11, Núm. 1

2009

  1. Evaluation of three immunoehromatographie assays for detection of legionella pneumophila serogroup 1 antigen in urine samples

    Revista Espanola de Quimioterapia, Vol. 22, Núm. 4, pp. 207-209

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2004

  1. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae

    International Journal of Antimicrobial Agents, Vol. 24, Núm. 2, pp. 185-187

  2. Recurrent Post-Traumatic Scytalidium dimidiatum Fungal Endophthalmitis

    Clinical Microbiology Newsletter, Vol. 26, Núm. 6, pp. 44-46

2003

  1. Legionnaires' disease outbreak in Murcia, Spain

    Emerging Infectious Diseases, Vol. 9, Núm. 8, pp. 915-921

  2. Sensibilidad a antimicrobianos de aislamientos clínicos de Pseudomonas aeruginosa en Murcia

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 444-449

2001

  1. Estudio comparativo de tres pruebas de sensibilidad de mycobacterium tuberculosis a fármacos antituberculosos de primera línea

    Revista Espanola de Quimioterapia, Vol. 14, Núm. 1, pp. 40-46

  2. Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones

    Journal of Antimicrobial Chemotherapy, Vol. 47, Núm. 2, pp. 157-161

1999

  1. Efflux pump-mediated quinolone resistance in staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 354-356

  2. In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 4, pp. 966-968

1998

  1. Analysis of grlA mutations in clinical isolates of Staphylococcus aureus with different levels of quinolone resistance [3]

    Antimicrobial Agents and Chemotherapy

  2. Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter

    Scandinavian Journal of Infectious Diseases, Vol. 30, Núm. 4, pp. 421-423

1997

  1. Assessment of multiple coagulase-negative staphylococci isolated in blood cultures using pulsed-field gel electrophoresis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 16, Núm. 8, pp. 581-586

  2. Estado actual del tratamiento farmacologico de la leishmaniasis

    Revista Espanola de Quimioterapia, Vol. 10, Núm. 1, pp. 26-35

1996

  1. Characterisation of the novel junctions of two minichromosomes of Leishmania major

    Molecular and Biochemical Parasitology, Vol. 82, Núm. 2, pp. 137-144

  2. Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by a multiplex-polymerase chain reaction

    Journal of Applied Bacteriology, Vol. 80, Núm. 6, pp. 596-604

  3. Evaluation of mtp40 genomic fragment amplification for specific detection of Mycobacterium tuberculosis in clinical specimens

    Journal of Clinical Microbiology, Vol. 34, Núm. 5, pp. 1108-1113

  4. In-vitro activity of a new quinolone, clinafloxacin, against clinical isolates of Corynebacterium species [2]

    Journal of Antimicrobial Chemotherapy

  5. Lesión tuberosa en dorso de la mano en paciente inmunocompetente

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 14, Núm. 1, pp. 55-56